04 oct
|
412 Eli Lilly y Compañía de México S.A de
|
Ciudad de México
04 oct
412 Eli Lilly y Compañía de México S.A de
Ciudad de México
Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life‐changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, self‐less work—but it's work worth doing. We are a integral healthcare leader headquartered in Indianapolis, and in Mexico we have been making medicines since 1908. Driven by our enduring values of Integrity, Excellence, and Respect for People, we put people first — in our labs, in our communities, and in our workplaces.
The Opportunity Neuroscience
Neuroscience is one of Lilly's most enduring scientific commitments, and Alzheimer's disease is among the fastest-moving fields in medicine — moving from symptomatic management toward biologically confirmed diagnosis, earlier detection, and intervention in the early symptomatic stages of disease. As a Medical Science Liaison (MSL), you will be a credible, field-based scientific partner: translating complex evidence into clinical practice,
building trust‐based relationships with healthcare experts, and generating the insights that shape Lilly's medical strategy in México — in a therapeutic area where the diagnostic pathway itself must be strengthened alongside the science.
Maintain expert command of the evidence across Alzheimer's disease and the wider neurodegeneration landscape — amyloid and tau biology, fluid and imaging biomarkers, cognitive and functional endpoints, and Lilly's current and pipeline neuroscience assets, engaging on investigational assets only in a reactive, compliant manner. Translate clinical trial data, real‐world evidence, HEOR outputs, and updates to diagnostic criteria and clinical guidance (NIA‐AA, IWG, AAN, Alzheimer's Association appropriate‐use recommendations, Academia Mexicana de Neurología) into clear, balanced, guideline‐aligned scientific narratives. Discuss safety and monitoring considerations for this class of therapies — in
📌 Medical Science Liaison — Neuroscience (Ciudad de México)
🏢 412 Eli Lilly y Compañía de México S.A de
📍 Ciudad de México